Cercare Medical, a developer of neuroimaging software, announced FDA 510(k) clearance for the company’s Cone-Beam CT Perfusio ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the publication of results from the RAGE study of ...

Amplifi Vascular announced the initiation of the AMPLIFI-1 pivotal trial evaluating the safety and effectiveness of the Amplifi vei ...

Arsenal Medical announced that the FDA granted investigational device exemption approval for the RADIANT pivotal trial. The ...

Nectero Therapeutics announced the release of 2-year outcomes from the company’s first-in-human (FIH) trial of the investigat ...

Endologix announced the acquisition of the Pounce thrombectomy system from Surmodics, expanding the company’s portfolio of pe ...

Artivion, Inc. announced that it has completed the acquisition of its long-standing partner Endospan Ltd. On May 8, Artivion announ ...

Cagent Vascular, Inc. announced the successful completion of the first-in-human-use (FIH) procedures with the Serranator Sonic intr ...

Medtronic Neurovascular announced that its Onyx Liquid Embolic System (LES), Onyx 18 and Onyx 34, received FDA approval for a shake ...

Rationale for use of optical coherence tomography during BTK intervention, procedural steps, limitations, and future considerations.

Calcified femoropopliteal arterial disease remains a major challenge in endovascular therapy. Vessel preparation technologies have emerged to improve ...

Ms. Pouncey discusses the WARRIORS trial of EVAR in women with small AAAs, her health equity–focused research approach, fully automated volume segmentation for AAA assessment, and cultural challenges ...